Dmytro Kharkov

Pacific Biosciences of California technology maps cancer structural variants in single platform advance

Pacific Biosciences of California technology maps cancer structural variants in single platform advance
Cancer genomics breakthrough technology

Pacific Biosciences of California unveils new research using its PacBio HiFi technology to map hundreds of structural variants, novel isoforms, and critical fusions in cancer genomics.

The platform aims to predict patient survival and guide treatment decisions, capturing complex genetic insights in one comprehensive workflow. This innovation has the potential to transform cancer research and clinical applications.

Pacific Biosciences’ expanding suite of genomic solutions continues to drive advancements in precision medicine, building on its earlier introduction of automatic epigenetic detection in HiFi sequencing for enhanced data accuracy. Recent developments not only map structural variants in cancer but also reflect progress in integrating comprehensive epigenetic sequencing, as highlighted by the company’s move to enable automatic detection of 5mC and 6mA in its workflows.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.